EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Financial Toxicity and Breast Cancer: Why Does It Matter, Who Is at Risk, and How Do We Intervene?

Kamaria L Lee iD, Alexandru Eniu iD, Christopher M Booth iD, Molly MacDonald, Fumiko Chino iD

American Society of Clinical Oncology Educational Book · 2025-06 · 45 (3)

DOI: 10.1200/edbk-25-473450 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2025-06. Verfasst von Kamaria L Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Breast Neoplasms, Cost of Illness. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 97 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Financial toxicity, or the financial burden patients experience because of medical costs, can lead to negative patient effects including lower quality of life, compromised clinical care, and worse health outcomes. People with cancer and survivors are more likely to have financial toxicity than those without cancer, and patients with breast cancer are uniquely at risk. Patients with breast cancer often require multimodal treatment (surgery, radiation, and/or systemic therapy) and adjuvant hormonal therapy can continue for years after primary treatment. With improved disease outcomes, patients with breast cancer have prolonged survivorship often lasting decades but may carry chronic toxicities from treatment; both ongoing treatment of metastatic disease and long-term surveillance include continued tests, imaging, and medical visits that add to the cumulative burden on patients and their families. Additionally, breast cancer predominately affects women, who are more likely to have dual caregiver responsibilities, and increasingly is diagnosed in younger patients, who may have fertility preservation expenses and are more likely to experience education and/or employment disruption. When faced with high costs, patients may face difficult decisions regarding what sacrifices they are willing to endure to receive care. Interventions designed to reduce financial toxicity are moving out of the pilot phase, and ongoing randomized trials are expected to provide evidence into the effectiveness of financial navigation programs. Further work to address financial toxicity in breast cancer at the patient-provider, institutional, and governmental levels is needed for comprehensively better financial outcomes and quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCost of IllnessHumansFemaleQuality of LifeHealth Care Costs

Autor:innen und Institutionen

  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • European School of Oncology, Bellinzona, Switzerland.
  • Hôpital Riviera-Chablais, Rennaz, Switzerland.
  • Clinique de Genolier, Genolier, Switzerland.
  • Division of Cancer Care and Epidemiology, Cancer Research Institute and Departments of Oncology and Public Health Sciences, Queen's University, Kingston, ON, Canada.
  • Pink Fund, Southfield, MI.

ORCID-Profile: Kamaria L Lee, Alexandru Eniu, Christopher M Booth, Fumiko Chino

Zitieren

APA

Lee, K. L., Eniu, A., Booth, C. M., MacDonald, M., & Chino, F. (2025). Financial Toxicity and Breast Cancer: Why Does It Matter, Who Is at Risk, and How Do We Intervene?. American Society of Clinical Oncology Educational Book, 45(3). https://doi.org/10.1200/edbk-25-473450

Vancouver

Lee KL, Eniu A, Booth CM, MacDonald M, Chino F. Financial Toxicity and Breast Cancer: Why Does It Matter, Who Is at Risk, and How Do We Intervene?. American Society of Clinical Oncology Educational Book. 2025;45(3). doi:10.1200/edbk-25-473450

BibTeX
@article{Lee2025,
  author = {Lee, Kamaria L and Eniu, Alexandru and Booth, Christopher M and MacDonald, Molly and Chino, Fumiko},
  title = {Financial Toxicity and Breast Cancer: Why Does It Matter, Who Is at Risk, and How Do We Intervene?},
  journal = {American Society of Clinical Oncology Educational Book},
  year = {2025},
  volume = {45},
  number = {3},
  doi = {10.1200/edbk-25-473450}
}
Kostenlos starten →